维普中文期刊产品整合服务
24篇 您的检索式:作者名="Ginsberg LC"
    题名 作者 年代 出处 被引量
1非诺贝特治疗与2型糖尿病患者长期心血管病风险的关系显示文摘2型糖尿病患者心血管病风险高,部分原因在于高三酰甘油和低高密度脂蛋白胆固醇血症。而在他汀类药物治疗基础上,加强降低三酰甘油治疗,能否降低这种风险尚不清楚。该研究的目的是在使用他汀类药物治疗的2型糖尿病患者中,确定非诺贝特能否降低心血管病风险。刘莉 叶鹏 Elam MB Ginsberg HN Lovato LC Corson M Largay J Leiter LA Lopez C O'Connor PJ Sweeney ME Weiss D Friedewald WT Buse JB Gerstein HC Probstfield J Grimm R Ismail-Beigi F Goff DC Jr Fleg JL Rosenberg Y Byington RP ACCORDION study investigators 2017中华高血压杂志2017,25,6:7
2Effects of combination lipid therapy in type 2 diabetes mellitus显示文摘Ginsberg HN Elam MB Lovato LC New England Journal of Medicine0,,:4
3Effects of combination lipid therapy in type 2 diabetes mellitus显示文摘Ginsberg HN Elam MB Lovato LC 2010N Engl J Med2010,362,17:1
4Effects of combination lipid therapy in type 2 diabetes mellitus显示文摘Ginsberg HN Elam MB Lovato LC 2010N Engl J Med2010,362,17:1
5Effects of combination lipid thera-py in type2diabetes mellitus显示文摘Ginsberg HN Elam MB Lovato LC 2010N Engl J Med2010,62,17:1
6Effects of combination lipid therapy in type 2 diabetes mellitus显示文摘Ginsberg HN Elam MB Lovato LC 2010N Engl J Med2010,362,17:1
7Effects of combination lipid therapy in type 2 diabetes mellitus 显示文摘Ginsberg HN Elam MB Lovato LC 2010N Engl J Med2010,362,17:1
8Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes(ACCORD)trial显示文摘Ginsberg HN Bonds DE Lovato LC 0,,2:1
9Effects of combination lipid therapy in type 2 diabetes Mellitus显示文摘Ginsberg HN Elam MB Lovato LC 2010N Engl J Med2010,362,17:1
10Effects of combination lipid therapy in type2diabetes mellitus显示文摘Ginsberg HN Elam MB Lovato LC 2010N Engl J Med2010,362,:1
11Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus 显示文摘Ginsberg HN Elam MB Lovato LC 2010N Engl J Med2010,362,17:1
12Effects of combination lipid therapy in type 2 diabetes mellitus显示文摘Ginsberg HN Elam MB Lovato LC 2010N Engl J Med2010,362,17:1
13Effects of combination lipid therapy in type 2 diabetes mellitus显示文摘Ginsberg HN Elam MB Lovato LC 2010N Engl J Med2010,362,17:1
14Role of fibrates in cardiovas- cular disease prevention, the ACCORD Lipid perspective显示文摘Elam M Lovato LC Ginsberg H 2011Curt Opin Lipidol2011,22,1:1
15Effects of combination lipid therapy in type 2 diabetes mellitus显示文摘Ginsberg HN Elam MB Lovato LC 2010N Eng J Med2010,362,17:1
16Role of fibrates in cardiovascular disease prevention,the ACCORD-lipid perspective显示文摘Elam M Lovato LC Ginsberg H 2011Curr Opin Lipidol2011,1,22:1
17Evolution of the lipid trial protocol of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial显示文摘Ginsberg HN Bonds DE Lovato LC 2007Am J Cardiol2007,99,12:1
18Effects of combination lipid therapy in type 2 diabetes mellitus显示文摘Ginsberg HN Elam MB Lovato LC 2010N Engl J Med2010,362,17:1
19Effects of combination lip- id therapy in type 2 diabetes mellitus显示文摘Ginsberg HN Elam MB Lovato LC 2010N Engl J Med2010,362,17:1
20Evolution of the lipid trial protocol of the action to control cardiovascular risk in diabetes (ACCORD) trial显示文摘GINSBERG HN BONDS DE LOVATO LC et nl 2007Am J Cardiol2007,99,12:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费